I, Nicholas J. Campbell nominated by France, member of the Medical and Chemicals Technical Options Committee and CFC-11 Task Force, declare as follows:
1) I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2) I work for ARKEMA SA, based in Paris, as the Environment Manager for the Fluorinated Products Division.
3) This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4) My interests include the following –
a. Proprietary interests: I do not have a proprietary interest in a substance, technology or process (e.g., ownership of a patent) to be considered by the Technology and Economic Assessment Panel or any of its technical options committees or temporary subsidiary bodies.
b. Financial interests: I have stock options in ARKEMA SA. ARKEMA SA is a producer of HCFCs, HFCs and HFOs.
c. Employment, consultancy, directorship or other positions: I am Chairman of the European Fluorocarbon Technical Committee (EFCTC) that represents the producers of fluorocarbons in the European Union. I am also a member of the World Bank’s Ozone Operations Resource Group.
d. Government advice and other policy development: I do not provide advice on significant issues to a government with respect to its implementation of the Montreal Protocol or engage in the development of significant policy positions of a government for a Montreal Protocol meeting.
e. Paid research activities, fellowships or grants: I do not receive any paid research activities or any fellowships or grants for work related to a proposed use of an ozone-depleting substance or an alternative to a proposed use of an ozone depleting substance.
f. Other interests: I do not have other interests related to the subject matter of the Technology and Economic Assessment Panel or the Montreal Protocol.
5) ARKEMA SA supports my participation and travel on MCTOC and CFC-11 Task Force.
6) Pursuant to paragraph 11 of the COI Guidelines I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7) I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8) I undertake to make further declarations of interest annually for so long as I remain a member of the Medical and Chemicals Technical Options Committee and CFC-11 Task Force.
9) I understand that this DOI will expire no later than one year after I have signed it.
Signed: Nicholas J. Campbell (signed electronically by submission)
Date: 08th April, 2021